Cart
sales@molnova.com
BPTES
CAS No. 314045-39-1
BPTES( BPTES )
Catalog No. M18414 CAS No. 314045-39-1
BPTES(IC50 of 0.16 μM) is an effective and specific GlutamiN/Ase GLS1 (KGA) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 77 | In Stock |
|
| 2MG | 42 | In Stock |
|
| 5MG | 60 | In Stock |
|
| 10MG | 77 | In Stock |
|
| 25MG | 145 | In Stock |
|
| 50MG | 213 | In Stock |
|
| 100MG | 318 | In Stock |
|
| 200MG | 462 | In Stock |
|
| 500MG | 756 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBPTES
-
NoteResearch use only, not for human use.
-
Brief DescriptionBPTES(IC50 of 0.16 μM) is an effective and specific GlutamiN/Ase GLS1 (KGA) inhibitor.
-
DescriptionBPTES is a selective inhibitor of Glutaminase GLS1 (KGA), which is found in the kidney and brain, and is positively regulated by myc and strongly expressed in many tumors and tumor cell lines. BPTES has a K(i) of approx. 3 microM. BPTES inhibits the allosteric activation caused by phosphate binding and promotes the formation of an inactive complex.
-
In Vitro——
-
In Vivo——
-
SynonymsBPTES
-
PathwayChromatin/Epigenetic
-
TargetSirtuin
-
RecptorGlutaminase GLS1 (KGA)
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number314045-39-1
-
Formula Weight524.68
-
Molecular FormulaC24H24N6O2S3
-
Purity>98% (HPLC)
-
SolubilityDMSO : 50 mg/mL 95.30 mM;H2O : < 0.1 mg/mL
-
SMILESO=C(Cc1ccccc1)Nc1nnc(s1)CCSCCc1sc(nn1)NC(=O)Cc1ccccc1
-
Chemical NameN,N'-((thiobis(ethane-2,1-diyl))bis(1,3,4-thiadiazole-5,2-diyl))bis(2-phenylacetamide)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Le A., et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab. 2012 Jan 4;15(1):110-21.
molnova catalog
related products
-
lithospermic acid B
lithospermic acid B is a water-soluble antioxidant from Salvia extract. It plays significant role of antioxidant effect; antiplatelet aggregation anticoagulant and antithrombotic effect.
-
WAY-323061
WAY-323061 is a SIRT2 inhibitor.
-
RK-9123016
RK-9123016 is a SIRT2 inhibitor. RK-9123016 increases the acetylation level of eukaryotic translation initiation factor 5A (eIF5A), a physiological substrate of SIRT2, and reduces cell viability of human breast cancer cells accompanied with a decrease in c-Myc expression.
